Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Misoprostol for Blood Loss in Cesarean Section
NCT07712510Phase 4Completed
- Sponsor
- Medicare Hospital
- Start
- Mar 2025
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hemorrhage (2 arms), sponsored by Medicare Hospital. Primary endpoint: Reduction in Hemoglobin at 2 hours. Started Mar 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT07712510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07712510.